Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial
Titel:
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial
Auteur:
Cariou, B. Leiter, L.A. Müller-Wieland, D. Bigot, G. Colhoun, H.M. Del Prato, S. Henry, R.R. Tinahones, F.J. Letierce, A. Aurand, L. Maroni, J. Ray, K.K. Bujas-Bobanovic, M.